CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to ...

The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of ...

The trial aims to evaluate the therapy’s tolerability, pharmacokinetics and safety in around 56 healthy volunteers.